Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
Nuvation Bio Inc (NYSE: NUVB) closed the day trading at $1.89 down -3.57% from the previous closing price of $1.96. In other words, the price has decreased by -$3.57 from its previous closing price. On the day, 3.53 million shares were traded. NUVB stock price reached its highest trading level at $1.935 during the session, while it also had its lowest trading level at $1.86.
Ratios:
For a better understanding of NUVB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.04 and its Current Ratio is at 9.04. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on March 27, 2024, Upgraded its rating to Buy and sets its target price to $10 from $1.40 previously.
On March 26, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $5.
Jefferies Downgraded its Buy to Hold on January 06, 2023, whereas the target price for the stock was revised from $5 to $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 11 ’24 when Wang Junyuan Jerry sold 56,361 shares for $2.89 per share. The transaction valued at 162,883 led to the insider holds 3,866,228 shares of the business.
Mashal Robert bought 100,000 shares of NUVB for $220,000 on Oct 08 ’24. The Director now owns 100,000 shares after completing the transaction at $2.20 per share. On Jun 25 ’24, another insider, Cui Xiangmin, who serves as the Director of the company, bought 277,895 shares for $2.97 each. As a result, the insider paid 825,348 and bolstered with 2,453,131 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NUVB now has a Market Capitalization of 640103296 and an Enterprise Value of 146326032. For the stock, the TTM Price-to-Sale (P/S) ratio is 81.33 while its Price-to-Book (P/B) ratio in mrq is 1.38. Its current Enterprise Value per Revenue stands at 18.586 whereas that against EBITDA is -0.877.
Stock Price History:
The Beta on a monthly basis for NUVB is 1.43, which has changed by -0.16000003 over the last 52 weeks, in comparison to a change of 0.086116076 over the same period for the S&P500. Over the past 52 weeks, NUVB has reached a high of $4.16, while it has fallen to a 52-week low of $1.67. The 50-Day Moving Average of the stock is -16.94%, while the 200-Day Moving Average is calculated to be -29.74%.
Shares Statistics:
Over the past 3-months, NUVB traded about 2.49M shares per day on average, while over the past 10 days, NUVB traded about 3214480 shares per day. A total of 336.84M shares are outstanding, with a floating share count of 226.82M. Insiders hold about 33.03% of the company’s shares, while institutions hold 45.77% stake in the company. Shares short for NUVB as of 1740700800 were 24656256 with a Short Ratio of 9.89, compared to 1738281600 on 25210922. Therefore, it implies a Short% of Shares Outstanding of 24656256 and a Short% of Float of 10.190000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
